Results 21 to 30 of about 34,662 (239)

Spectrophotometric analysis of thrombolytic activity: SATA assay [PDF]

, 2017
Introduction: Measurement of thrombolytic activity i.e. clot lysis is crucial for research and development of novel thrombolytics. It is also a key factor in assessment of the effectiveness of conventionally used thrombolytic agents in the clinic, which ...
Entekhabi, Nazila, Eskandani, Morteza, Farhoudi, Mehdi, Mohammadian, Reza, Rafi, Mohammad, Zamanlu, Masumeh   +5 more
core   +2 more sources

Non-sterile Submerged Fermentation of Fibrinolytic Enzyme by Marine Bacillus subtilis Harboring Antibacterial Activity With Starvation Strategy

Frontiers in Microbiology, 2019
Microbial fibrinolytic enzyme is a promising candidate for thrombolytic therapy. Non-sterile production of fibrinolytic enzyme by marine Bacillus subtilis D21-8 under submerged fermentation was realized at a mild temperature of 34°C, using a unique ...
Shihan Pan, Guiguang Chen, Rui Wu, Xiaoyan Cao, Zhiqun Liang   +4 more
doaj   +1 more source

Fibrinolytic Enzyme from Green Microalgae: A New Potential Drug for Thrombolytic Therapy?

Phycology, 2023
Thrombosis is characterized by the pathological formation of fibrin clots within a blood vessel, leading to the obstruction of blood flow. Fibrinolytic enzymes from microorganisms have been shown to be more efficient and safer in dissolving clots.
Yanara Alessandra Santana Moura, Ariadne Tennyle Vieira De Souza, Páblo Eugênio Da Costa e Silva, Marllyn Marques Da Silva, Ana Lúcia Figueiredo Porto, Raquel Pedrosa Bezerra   +5 more
doaj   +1 more source

Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris [PDF]

, 2002
Objective: To evaluate the effects of moderate weight loss, in overweight patients with angina, on plasma coagulation, fibrinolytic indicies and pain frequency.
Hankey, C.R., Lean, M.E.J., Lowe, G.D.O., Rumley, A., Woodward, M.   +4 more
core   +1 more source

Food Origin Fibrinolytic Enzyme With Multiple Actions

Hayati Journal of Biosciences, 2018
Many health related problems such as cardiovascular diseases are associated with the formation of excessive clot in the blood (thrombus). Approaches in cardiovascular disease treatment are preventing the formation or removing the thrombus.
Laurentia Stephani, Raymond Rubianto Tjandrawinata, Diana Nur Afifah, Yanti Lim, Wangsa Tirta Ismaya, Maggy Thenawidjaja Suhartono   +5 more
doaj   +1 more source

Biosimilar tenecteplase versus alteplase in acute ischemic stroke: A real world study

Annals of Indian Academy of Neurology, 2023
Background and Purpose: There is an unmet need for a more effective thrombolytic agent in acute ischemic stroke (AIS) management. Various studies and meta-analysis suggest tenecteplase (TNK) as non-inferior over alteplase (rTPA).
Ayush Mohan, Snigdha Komakula, Suhas Murali, Pooja Anand, Dyuti Shah, V Y Vishnu, Awadh Kishor Pandit, Ayush Agarwal, Deepti Vibha, Mamta Bhushan Singh, M V Padma Srivastava, Rohit Bhatia   +11 more
doaj   +1 more source

Food Origin Fibrinolytic Enzyme With Multiple Actions

Hayati Journal of Biosciences, 2017
Many health related problems such as cardiovascular diseases are associated with the formation of excessive clot in the blood (thrombus). Approaches in cardiovascular disease treatment are preventing the formation or removing the thrombus.
Laurentia Stephani, Raymond Rubianto Tjandrawinata, Diana Nur Afifah, Yanti Lim, Wangsa Tirta Ismaya, Maggy Thenawidjaja Suhartono   +5 more
doaj   +1 more source

Clinically Significant Thromboembolic Disease in Adult Spinal Deformity Surgery: Incidence and Risk Factors in 737 Patients. [PDF]

, 2017
Study Design:Retrospective cohort study. Objectives:Describe the rate and risk factors for venous thromboembolic events (VTEs; defined as deep venous thrombosis [DVT] and/or pulmonary embolism [PE]) in adult spinal deformity (ASD) surgery.
Bess, Shay, Burton, Douglas, Diebo, Basel G, Hart, Robert, International Spine Study Group (ISSG), Iyer, Sravisht, Kelly, Michael P, Kim, Han Jo, Klineberg, Eric O, Lafage, Virginie, Mundis, Gregory M, Schwab, Frank, Sciubba, Daniel, Shaffrey, Christopher I, Smith, Justin S   +14 more
core   +1 more source

Admission Tpe interval predicts reperfusion success in STEMI patients treated with fibrinolytic agents

Türk Kardiyoloji Derneği Arşivi, 2020
Objective: Myocardial infarction is a leading cause of morbidity and mortality. Fibrinolytic administration is still a life-saving choice in ST-segment elevated myocardial infarction (STEMI), but the rate of successful reperfusion can be inconsistent ...
Ali Çoner, Sinan Akıncı, Mehmet Hüsamettin Akküçük, Cihan Altın, Haldun Müderrisoğlu   +4 more
doaj   +1 more source

Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role

Life, 2023
Blood clot formation in blood vessels (thrombosis) is a major cause of life-threatening cardiovascular diseases. These clots are formed by αA-, βB-, and ϒ-peptide chains of fibrinogen joined together by isopeptide bonds with the help of blood coagulation
Rajni Singh, Prerna Gautam, Chhavi Sharma, Alexander Osmolovskiy   +3 more
doaj   +1 more source